Clinical significance of circulating tumor cells in peripheral blood from patients with gastric cancer

Cancer

Volumn 119, Issue 22, 2013, Pages 3984-3991

  Uenosono, Yoshikazu ^a   Arigami, Takaaki ^a   Kozono, Tsutomu ^a   Yanagita, Shigehiro ^a   Hagihara, Takahiko ^a   Haraguchi, Naoto ^a   Matsushita, Daisuke ^a   Hirata, Munetsugu ^a   Arima, Hideo ^a   Funasako, Yawara ^a   Kijima, Yuko ^a   Nakajo, Akihiro ^a   Okumura, Hiroshi ^a   Ishigami, Sumiya ^a   Hokita, Shuichi ^b   Ueno, Shinichi ^a   Natsugoe, Shoji ^a  

^a KAGOSHIMA UNIVERSITY   (Japan)

^b Jiaikai Imamura Hospital   (Japan)

Author keywords

circulating tumor cells; gastric cancer; hematogenous recurrence; peritoneal dissemination; prognosis

Indexed keywords

CISPLATIN; GIMERACIL PLUS OTERACIL POTASSIUM PLUS TEGAFUR; PACLITAXEL;

ADULT; AGED; ANOREXIA; ARTICLE; BLOOD ANALYSIS; CANCER CHEMOTHERAPY; CANCER GROWTH; CANCER PATIENT; CANCER PROGNOSIS; CELL COUNT; CELL ISOLATION; CIRCULATING TUMOR CELL; COHORT ANALYSIS; CONTROLLED STUDY; DISTANT METASTASIS; DRUG TOLERABILITY; FEMALE; GASTRECTOMY; HUMAN; HUMAN CELL; LEUKOPENIA; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; PERITONEUM METASTASIS; PRIORITY JOURNAL; RECURRENCE FREE SURVIVAL; RECURRENT CANCER; STOMACH CANCER; SURVIVAL RATE;

CIRCULATING TUMOR CELLS; GASTRIC CANCER; HEMATOGENOUS RECURRENCE; PERITONEAL DISSEMINATION; PROGNOSIS;

ADULT; AGED; AGED, 80 AND OVER; CELL LINE, TUMOR; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEOPLASTIC CELLS, CIRCULATING; STOMACH NEOPLASMS; SURVIVAL RATE; TUMOR MARKERS, BIOLOGICAL;

EID: 84887083101     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/cncr.28309     Document Type: Article

References (25)

1. Yeh KH, Chen YC, Yeh SH, Chen CP, Lin JT, Cheng AL,. Detection of circulating cancer cells by nested reverse transcription-polymerase chain reaction of cytokeratin-19 (K19)-possible clinical significance in advanced gastric cancer. Anticancer Res. 1998; 18: 1283-1286.
2. Noh YH, Kim JA, Lim GR, et al. Detection of circulating tumor cells in patients with gastrointestinal tract cancer using RT-PCR and its clinical implications. Exp Mol Med. 2001; 33: 8-14.
3. Vogel I, Kalthoff H,. Disseminated tumour cells. Their detection and significance for prognosis of gastrointestinal and pancreatic carcinomas. Virchows Arch. 2001; 439: 109-117.
4. Ghossein RA, Bhattacharya S, Rosai J,. Molecular detection of micrometastases and circulating tumor cells in solid tumors. Clin Cancer Res. 1999; 5: 1950-1960.
5. Nakashima S, Natsugoe S, Matsumoto M, et al. Clinical significance of circulating tumor cells in blood by molecular detection and tumor markers in esophageal cancer. Surgery. 2003; 133: 162-169.
6. Mimori K, Fukagawa T, Kosaka Y, et al. A large-scale study of MT1-MMP as a marker for isolated tumor cells in peripheral blood and bone marrow in gastric cancer cases. Ann Surg Oncol. 2008; 15: 2934-2942.
7. Bertazza L, Mocellin S, Marchet A, et al. Survivin gene levels in the peripheral blood of patients with gastric cancer independently predict survival [serial online]. J Transl Med. 2009; 7: 111.
8. Wu CH, Lin SR, Hsieh JS, et al. Molecular detection of disseminated tumor cells in the peripheral blood of patients with gastric cancer: evaluation of their prognostic significance. Dis Markers. 2006; 22: 103-109.
9. Mimori K, Fukagawa T, Kosaka Y, et al. Hematogenous metastasis in gastric cancer requires isolated tumor cells and expression of vascular endothelial growth factor receptor-1. Clin Cancer Res. 2008; 14: 2609-2616.
10. Koga T, Tokunaga E, Sumiyoshi Y, et al. Detection of circulating gastric cancer cells in peripheral blood using real time quantitative RT-PCR. Hepatogastroenterology. 2008; 55: 1131-1135.
11. Arigami T, Uenosono Y, Ishigami S, Hagihara T, Haraguchi N, Natsugoe S,. Clinical significance of the B7-H4 coregulatory molecule as a novel prognostic marker in gastric cancer. World J Surg. 2011; 35: 2051-2057.
12. Cristofanilli M, Budd GT, Ellis MJ, et al. Circulating tumor cells, disease progression, and survival in metastatic breast cancer. N Engl J Med. 2004; 351: 781-791.
13. Leversha MA, Han J, Asgari Z, et al. Fluorescence in situ hybridization analysis of circulating tumor cells in metastatic prostate cancer. Clin Cancer Res. 2009; 15: 2091-2097.
14. Sobin LH, Gospodarowicz MK, Wittekind C, eds. TNM Classification of Malignant Tumours. 7th ed. Oxford, United Kingdom: Wiley-Blackwell; 2010.
15. Nishida S, Kitamura K, Ichikawa D, Koike H, Tani N, Yamagishi H,. Molecular detection of disseminated cancer cells in the peripheral blood of patients with gastric cancer. Anticancer Res. 2000; 20: 2155-2159.
16. Ikeguchi M, Ohro S, Maeda Y, et al. Detection of cancer cells in the peripheral blood of gastric cancer patients. Int J Mol Med. 2003; 11: 217-221.
17. Miyazono F, Natsugoe S, Takao S, et al. Surgical maneuvers enhance molecular detection of circulating tumor cells during gastric cancer surgery. Ann Surg. 2001; 233: 189-194.
18. Arigami T, Uenosono Y, Hirata M, Yanagita S, Ishigami S, Natsugoe S,. B7-H3 expression in gastric cancer: a novel molecular blood marker for detecting circulating tumor cells. Cancer Sci. 2011; 102: 1019-1024.
19. Saad AA, Awed NM, Abd Elkerim NN, et al. Prognostic significance of E-cadherin expression and peripheral blood micrometastasis in gastric carcinoma patients. Ann Surg. Oncol. 2010; 17: 3059-3067.
20. Sakuramoto S, Sasako M, Yamaguchi T, et al. Adjuvant chemotherapy for gastric cancer with S-1, an oral fluoropyrimidine. N Engl J Med. 2007; 357: 1810-1820.
21. Rahbari NN, Bork U, Kircher A, et al. Compartmental differences of circulating tumor cells in colorectal cancer. Ann Surg Oncol. 2012; 19: 2195-2202.
22. Budd GT, Cristofanilli M, Ellis MJ, et al. Circulating tumor cells versus imaging-predicting overall survival in metastatic breast cancer. Clin Cancer Res. 2006; 12: 6403-6409.
23. Nakamura S, Yagata H, Ohno S, et al. Multi-center study evaluating circulating tumor cells as a surrogate for response to treatment and overall survival in metastatic breast cancer. Breast Cancer. 2010; 17: 199-204.
24. Sakakura C, Hagiwara A, Nakanishi M, et al. Differential gene expression profiles of gastric cancer cells established from primary tumour and malignant ascites. Br J Cancer. 2002; 87: 1153-1161.
25. Hiraiwa K, Takeuchi H, Hasegawa H, et al. Clinical significance of circulating tumor cells in blood from patients with gastrointestinal cancers. Ann Surg. Oncol. 2008; 15: 3092-3100.